Evidence map›Paper›PMID 28320216›Full record

ArticleThe journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians2018

A neurologic dysfunction scoring protocol for jaundiced neonates requiring exchange transfusion.

Bolajoko O Olusanya, Folashade B Osibanjo, Adeniyi A Ajiboye, Oluwafemi E Ayodele, Adebanke A Odunsi, Serah M Olaifa, Abieyuwa A Emokpae

Abstract readEvaluation Study
In one paragraph

Article in The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bolajoko O Olusanyaa Center for Healthy Start Initiative , Lagos , Nigeria.
Folashade B Osibanjoa Center for Healthy Start Initiative , Lagos , Nigeria.
Adeniyi A Ajiboyeb Massey Street Children's Hospital , Lagos , Nigeria.
Oluwafemi E Ayodeleb Massey Street Children's Hospital , Lagos , Nigeria.
Adebanke A Odunsib Massey Street Children's Hospital , Lagos , Nigeria.
Serah M Olaifab Massey Street Children's Hospital , Lagos , Nigeria.
Abieyuwa A Emokpaeb Massey Street Children's Hospital , Lagos , Nigeria.

Funding

Determining Prevalence of Acute Bilirubin Encephalopathy in Developing CountriesR21HD068203 · NICHD · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI SLUSHER, TINA MARYE · 2012 to 2013
$223k
NICHD NIH HHS R21 HD068203
6 · The paper itself

Abstract

aimTo evaluate the performance of a neurologic assessment protocol among jaundiced infants requiring exchange transfusion (ET).

methodsWe identified infants in a referral children's hospital who received ET and those who met the American Academy of Pediatrics (AAP) criteria for ET based on total serum bilirubin (TSB) levels. The performance of a bilirubin-induced neurologic dysfunction (BIND-M) scoring protocol for acute bilirubin encephalopathy (ABE) in detecting infants treated with ET in both groups was investigated by logistic regression analysis and c-statistic.

resultsA total of 438 late-preterm and term infants were enrolled, out of which 141 (32.2%) received ET, and 155 (35.4%) met AAP criteria for ET. Infants with BIND-M scores of 3-6 (intermediate ABE) or 7-12 (advanced ABE) were significantly associated with ET in both groups, but not scores of 1-2 (mild ABE), with or without adjustment for confounding neurotoxicity risk factors. However, the discriminatory ability of BIND-M regression models was modestly satisfactory (c-statistic range: 0.693-0.791).

conclusionsOur findings suggest that BIND-M is a potentially useful decision-making tool for ET and support current recommendation for immediate ET for infants with intermediate-to-advanced stages of ABE regardless of the TSB levels.

Indexed as

Decision Support TechniquesExchange Transfusion, Whole BloodBilirubinCase-Control StudiesCross-Sectional StudiesFemaleGestational AgeHumansInfant, NewbornInfant, PrematureJaundice, NeonatalKernicterusLogistic ModelsMaleNigeriaSeverity of Illness IndexBilirubinAcute bilirubin encephalopathyexchange transfusionlate presentationneurological examinationnewborn care

Identifiers

PMID28320216
PMCPMC6166872

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.